Literature DB >> 8909580

12th International Histocompatibility Conference. Genetic diversity of HLA: functional and medical implications. Paris, France, June 9-12, 1996. Abstracts.

.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8909580

Source DB:  PubMed          Journal:  Hum Immunol        ISSN： 0198-8859            Impact factor:   2.850


× No keyword cloud information.
  8 in total

1.  Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.

Authors:  Ahmad Al-Sukaini; Francis J Hornicek; Zachary S Peacock; Leonard B Kaban; Soldano Ferrone; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2017-07-19       Impact factor: 4.176

2.  LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.

Authors:  Jacky T Yeung; Ronald L Hamilton; Koji Ohnishi; Maki Ikeura; Douglas M Potter; Marina N Nikiforova; Soldano Ferrone; Regina I Jakacki; Ian F Pollack; Hideho Okada
Journal:  Clin Cancer Res       Date:  2013-02-11       Impact factor: 12.531

3.  HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.

Authors:  Liz Y Han; Mavis S Fletcher; Diana L Urbauer; Peter Mueller; Charles N Landen; Aparna A Kamat; Yvonne G Lin; William M Merritt; Whitney A Spannuth; Michael T Deavers; Koen De Geest; David M Gershenson; Susan K Lutgendorf; Soldano Ferrone; Anil K Sood
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

4.  Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy.

Authors:  Jacky T Yeung; Ronald L Hamilton; Hideho Okada; Regina I Jakacki; Ian F Pollack
Journal:  J Neurooncol       Date:  2012-11-21       Impact factor: 4.130

5.  Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis.

Authors:  Manas Ranjan Dikhit; Akhilesh Kumar; Sushmita Das; Budheswar Dehury; Ajaya Kumar Rout; Fauzia Jamal; Ganesh Chandra Sahoo; Roshan Kamal Topno; Krishna Pandey; V N R Das; Sanjiva Bimal; Pradeep Das
Journal:  Front Immunol       Date:  2017-12-14       Impact factor: 7.561

6.  Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.

Authors:  Shinji Matsutani; Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Tatsunari Fukuoka; Shigetomi Nakao; Kosei Hirakawa; Masaichi Ohira
Journal:  Cancer Sci       Date:  2018-03-25       Impact factor: 6.716

7.  High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease.

Authors:  Sjoerd P F T Nota; Ahmad Al-Sukaini; Shalin S Patel; Francesco Sabbatino; G Petur Nielsen; Vikram Deshpande; Jennifer H Yearley; Soldano Ferrone; Xinhui Wang; Joseph H Schwab
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 5.738

8.  Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.

Authors:  Pierre Dillard; Hakan Köksal; Solrun Melkorka Maggadottir; Anna Winge-Main; Sylvie Pollmann; Mathilde Menard; Marit Renée Myhre; Gunhild M Mælandsmo; Vivi Ann Flørenes; Gustav Gaudernack; Gunnar Kvalheim; Sébastien Wälchli; Else Marit Inderberg
Journal:  Mol Ther       Date:  2020-11-17       Impact factor: 11.454
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.